Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Share News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,732.00
Bid: 1,728.00
Ask: 1,734.00
Change: -38.00 (-2.15%)
Spread: 6.00 (0.347%)
Open: 1,784.00
High: 1,784.00
Low: 1,720.00
Prev. Close: 1,770.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Genus' company secretary lowers stake

Mon, 20th Apr 2020 15:56

(Sharecast News) - Genus revealed on Monday that general counsel and company secretary Dan Hartley had offloaded 7,500 ordinary shares in the FTSE 250-listed animal semen merchant.
Hartley, who took over the role back in June 2014, disposed of the shares on Friday at an average price of 3,610p each, for a total value of ?270,749.99.

Back in February, Genus reported "strong" revenue growth of 13% in actual and constant currency in its half-year results to ?270.7m.

Genus said it saw "excellent" performance in its PIC porcine generics division, with revenue there up 15% for the six months ended 31 December, while royalty revenues grew 9%, with growth seen in all regions.

As of 1640 BST, Genus shares were up 1.28% at 3,646p.

Top Director Buys

Sabre Insurance Group (SBRE)
Director name: Westwood,Adam Richard
Amount purchased: 648 @ 27,738.00p
Value: ?179,742.24

Intercede Group (IGP)
Director name: Leest ,Klaas van der
Amount purchased: 35,000 @ 53.75p
Value: ?18,812.50

Hammerson (HMSO)
Director name: Bouchut,Pierre
Amount purchased: 20,279 @ 68.10p
Value: ?13,810.00

Tr European Growth Trust (TRG)
Director name: Mettenheimer,Alexander
Amount purchased: 1,000 @ 704.00p
Value: ?7,040.00

Tr European Growth Trust (TRG)
Director name: Mettenheimer,Alexander
Amount purchased: 1,000 @ 690.00p
Value: ?6,900.00

Oxford Biodynamics (OBD)
Director name: Diggle,Stephen Charles
Amount purchased: 8,397 @ 52.00p
Value: ?4,366.44

Oxford Biodynamics (OBD)
Director name: Diggle,Stephen Charles
Amount purchased: 7,805 @ 50.00p
Value: ?3,902.50

Ocado Group (OCDO)
Director name: Abrams,Neill
Amount purchased: 10 @ 1,484.50p
Value: ?148.45

Ocado Group (OCDO)
Director name: Steiner,Tim
Amount purchased: 10 @ 1,484.50p
Value: ?148.45

Ocado Group (OCDO)
Director name: Richardson,Mark
Amount purchased: 10 @ 1,484.50p
Value: ?148.45

Ocado Group (OCDO)
Director name: Jensen,Luke
Amount purchased: 10 @ 1,484.50p
Value: ?148.45

Ocado Group (OCDO)
Director name: Tatton-Brown,Duncan
Amount purchased: 10 @ 1,484.50p
Value: ?148.45

Tesco (TSCO)
Director name: Lewis,Dave
Amount purchased: 59 @ 235.92p
Value: ?139.19

Tesco (TSCO)
Director name: Stewart,Alan
Amount purchased: 58 @ 235.92p
Value: ?136.83

Severfield (SFR)
Director name: Dunsmore,Alan
Amount purchased: 185 @ 67.40p
Value: ?124.70

Severfield (SFR)
Director name: Cochrane,Ian
Amount purchased: 185 @ 67.40p
Value: ?124.70



Top Director Sells

Genus (GNS)
Director name: Hartley,Dan
Amount sold: 7,500 @ 3,610.00p
Value: ?270,749.99

Hammerson (HMSO)
Director name: Bouchut,Pierre
Amount sold: 20,279 @ 67.90p
Value: ?13,769.44

More News
12 Aug 2016 07:06

Genus suffers legal setback Stateside

(ShareCast News) - Genus suffered a legal setback Stateside as a US judge handed down a series of verdicts against the animal genetics specialist. The US District Court for Wisconsin ruled that two of Genus rival ST´s patents were valid and had been infringed and that ABS, a unit of Genus, had mater

Read more
11 Aug 2016 10:01

Genus and Sexing still battling over semen

(ShareCast News) - Animal genetics company Genus announced the first jury verdicts in its antitrust litigation against Inguran, operating as Sexing Technologies, relating to ABS's 'Genus Sexed Semen' processing technology. The FTSE 250 firm said that at the trial in the US District Court for the Wes

Read more
11 Aug 2016 07:45

Genus Says US Court Finds Against Inguran But Sees No Injury To Genus

Read more
4 Aug 2016 11:59

Thursday broker round-up

(ShareCast News) - Next: Goldman Sachs reiterates sell with a target price of 4800p. Standard Chartered: JP Morgan maintains overweight with a 800p target. Shire: JP Morgan reiterates overweight with a 6300p target. Genus: HSBC stays at buy with a 2200p target. Nichols: UBS keeps at buy with a ta

Read more
4 Jul 2016 08:37

BROKER RATINGS SUMMARY: Liberum Downgrades Property Stocks

Read more
4 Jul 2016 08:21

CORRECT (01/07): WINNERS & LOSERS SUMMARY

Read more
1 Jul 2016 15:58

LONDON MARKET CLOSE: Stocks Close Week After Brexit Vote On A High

Read more
1 Jul 2016 11:09

LONDON MARKET MIDDAY: Carney Boosts Stocks As easyJet Eyes Own Brexit

Read more
1 Jul 2016 09:11

WINNERS & LOSERS SUMMARY: Dignity And Genus Benefit From Upgrades

Read more
1 Jul 2016 08:51

BROKER RATINGS SUMMARY: Berenberg - Buy Dignity; Liberum - Buy Genus

Read more
1 Jul 2016 07:24

LONDON BRIEFING: Carney Lifts Brexit Blues With Policy Assurance

Read more
20 Jun 2016 09:25

ITV, Wolseley are Liberum's top-picks in case of Bremain, Brexit

(ShareCast News) - Depending on whether the UK finally decided to 'Remain' or 'Leave' then different London-listed securities were likelier to 'outperform' their respective sectors, Liberum said. The broker's 'top-picks' under a 'Remain', 'Leave' and 'Either way' scenario were, ITV, Wolseley and Bal

Read more
26 May 2016 14:30

FTSE 250 movers: Ibstock retreats as Pets at Home accelerates

(ShareCast News) - The FTSE 250 slipped further into the red late as Thursday wore on, despite having peeped its head above water around midday. Leading the index lower, shares in Ibstock subsided as the brick maker reported a slow start to the year for its UK clay business had lasted four months b

Read more
18 May 2016 09:49

Genus announces collaboration with Caribou Biosciences

(ShareCast News) - Genus announced a strategic collaboration with US-based Caribou Biosciences that will give the London-listed animal genetics group exclusive license to Caribou's gene editing technology platform. Caribou's CRISPR-Cas9 technology accurately targets and cuts DNA to produce precise a

Read more
18 May 2016 07:01

Genus Signs Gene Editing Platform Deal With Caribou Biosciences

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.